The Gold Trade, May 24
Health Care: Drugs
Sucampo Pharmaceuticals Inc. A (SCMP: NASDAQ)
$9.02 0.17 | 1.92%
05/24/13 - 04:00 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:98.33
Price Earnings Comparisons:
| SCMP | Sector Avg. | S&P 500 |
|---|---|---|
| 98.33 | 98.30 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| 70.19 | 16.24 | 147.21 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | 48.80 | 0.21 | 0.06 |
| Net Income | 0.00 | 0.00 | |
| EPS | -7.00 | 0.00 |
Earnings for SCMP:
| EBITDA | 9.87M |
| REVENUE | 81.49M |
Average Earnings Estimates
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $0.14 | $-0.11 | $-0.09 | $0.22 |
| Number of Analysts | 2 | 2 | 2 | 2 |
| High Estimate | $0.14 | $-0.04 | $0.01 | $0.54 |
| Low Estimate | $0.13 | $-0.18 | $-0.19 | $-0.11 |
| Prior Year | $-0.02 | $-0.14 | $0.12 | $-0.09 |
| Growth Rate (Year over Year) | 775.00% | 21.43% | -175.00% | 338.89% |
Portfolios with SCMP
- Portfolio NameUser Type
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Setting Up...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- UserGFNN Stockdiagnostics 5
- User©SUPRATRADE HOT STOCKS (...
Latest SCMP Headlines from TheStreet
- Sucampo Pharmaceuticals Inc. A Stock Downgraded (SCMP) 05.09.13 | 05:05 am
- 5 Stocks Under $10 Set to Soar 04.25.13 | 01:04 pm
- Sucampo Pharmaceuticals Inc. A Stock Upgraded (SCMP) 04.18.13 | 05:04 am
- Most Profitable Second Quarter Biotech Stocks 04.02.13 | 06:04 am
- 5 Stocks Under $10 Triggering Breakouts 03.14.13 | 01:03 pm
- Best And Worst FDA Drug Approval Stocks of 2013 03.12.13 | 08:03 am
- Sucampo Pharmaceuticals Inc. A Stock Downgraded (SCMP) 03.12.13 | 05:03 am
- Play TheStreet's FDA Drug Approval Contest 03.05.13 | 12:03 pm
- TheStreet Ratings Top 10 Rating Changes 01.14.13 | 10:01 am
- Sucampo Pharmaceuticals Inc. A Stock Upgraded (SCMP) 01.14.13 | 04:01 am
Press Releases for SCMP
- Sucampo Pharmaceuticals, Inc. Reports Fourth Quarter And Full Year 2012 Financial And Operating Results - Business Wire 03.13.13 | 05:03 pm
- Sucampo Pharmaceuticals Announces Fourth Quarter And Full Year 2012 Financial Results And Operating Highlights Teleconference And Webcast - Business Wire 03.06.13 | 06:03 am
- Sucampo Appoints Barbara A. Munder And Maureen E. O’Connell To Board Of Directors - Business Wire 03.01.13 | 06:03 am
- Sucampo Announces Commercial Availability Of RESCULA In U.S. Pharmacies - Business Wire 02.19.13 | 08:02 pm
- Sucampo Files Patent Infringement Lawsuit Against Anchen Pharmaceuticals And Par Pharmaceuticals - Business Wire 02.08.13 | 06:02 am
- Sucampo Pharmaceuticals To Present At Investment Conferences - Business Wire 02.06.13 | 06:02 am
- Sucampo Announces Japanese Government Funding For Unoprostone Isopropyl Development In Retinitis Pigmentosa - Business Wire 02.04.13 | 06:02 am
- Sucampo Pharmaceuticals Announces Webcast Of Its Presentation At The Biotech ShowcaseTM 2013 Conference - Business Wire 01.03.13 | 06:01 am
- Sucampo Announces FDA Approval Of An SNDA For RESCULA® (unoprostone Isopropyl) - Business Wire 12.12.12 | 06:12 am
- Sucampo Receives $15 Million Milestone Payment From Abbott On First Sale Of AMITIZA® (lubiprostone) In Japan - Business Wire 12.11.12 | 06:12 am
Partner Headlines for SCMP
- 5 Pharmaceutical Companies With EMA Or MHRA Catalysts This Year - Seeking Alpha 08.28.12 | 09:08 am
- Phase 3 Long-Term Safety Trial Results of Lubiprostone in Patients with Irritable Bowel Syndrome with Constipation was Recently Published in Alimentary Pharmacology and Therapeutics - Benzinga 03.06.12 | 04:03 pm
- Life Sciences Companies Raise Record Amounts of Capital - Seeking Alpha 12.31.10 | 04:12 pm
